Indivumed Therapeutics
Hamburg, Germany· Est. 2002
We discover novel targets for the development of precision cancer therapeutics.
Private Company
Total funding raised: $85M
About
We discover novel targets for the development of precision cancer therapeutics.
OncologyProteomicsBiologics
Funding History
2Total raised:$85M
Series B$60MJun 15, 2021
Series A$25MJun 15, 2018